EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery

Yasunari Matsuzaka, Ryu Yashiro

Pharmaceuticals · 30.05.2024 · 17 (6) · 707

DOI: 10.3390/ph17060707 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.05.2024. Verfasst von Yasunari Matsuzaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, T…. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) have emerged as a promising approach for drug delivery strategies because of their unique properties. These strategies include stem cell membrane-coated nanoparticles, stem cell-derived extracellular vesicles, immunomodulatory effects, stem cell-laden scaffolds, and scaffold-free stem cell sheets. MSCs offer advantages such as low immunogenicity, homing ability, and tumor tropism, making them ideal for targeted drug delivery systems. Stem cell-derived extracellular vesicles have gained attention for their immune properties and tumor-homing abilities, presenting a potential solution for drug delivery challenges. The relationship between MSC-based drug delivery and the self-renewal and differentiation capabilities of MSCs lies in the potential of engineered MSCs to serve as effective carriers for therapeutic agents while maintaining their intrinsic properties. MSCs exhibit potent immunosuppressive functions in MSC-based drug delivery strategies. Stem cell-derived EVs have low immunogenicity and strong therapeutic potential for tissue repair and regeneration. Scaffold-free stem cell sheets represent a cutting-edge approach in regenerative medicine, offering a versatile platform for tissue engineering and regeneration across different medical specialties. MSCs have shown great potential for clinical applications in regenerative medicine because of their ability to differentiate into various cell types, secrete bioactive factors, and modulate immune responses. Researchers are exploring these innovative approaches to enhance drug delivery efficiency and effectiveness in treating various diseases.

Schlagwörter

Stichwörter der Autor:innen

immunomodulatorymesenchymal stem cellscaffold-free stem cell sheetsstem cell membrane-coated nanoparticlesstem cell-derived extracellular vesiclesstem cell-laden scaffolds

Autor:innen und Institutionen

  • Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.
  • Administrative Section of Radiation Protection, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira 187-8551, Tokyo, Japan.
  • Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose 204-8588, Tokyo, Japan.
  • Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.

Zitieren

APA

Matsuzaka, Y., & Yashiro, R. (2024). Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery. Pharmaceuticals, 17(6), 707. https://doi.org/10.3390/ph17060707

Vancouver

Matsuzaka Y, Yashiro R. Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery. Pharmaceuticals. 2024;17(6):707. doi:10.3390/ph17060707

BibTeX
@article{Matsuzaka2024,
  author = {Matsuzaka, Yasunari and Yashiro, Ryu},
  title = {Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {6},
  pages = {707},
  doi = {10.3390/ph17060707}
}
Kostenlos starten →